{"id":11140,"date":"2026-11-02T09:23:59","date_gmt":"2026-11-02T14:23:59","guid":{"rendered":"https:\/\/www.inflation.us\/news\/?p=11140"},"modified":"2026-11-02T09:24:00","modified_gmt":"2026-11-02T14:24:00","slug":"can-any-stock-outperform-medicure","status":"publish","type":"post","link":"https:\/\/www.inflation.us\/news\/articles\/can-any-stock-outperform-medicure\/","title":{"rendered":"Can Any Stock Outperform Medicure?"},"content":{"rendered":"\n<div style=\"width:100%; max-width:650px; margin:0 auto; padding:0 10px; box-sizing:border-box; font-family:Arial,Helvetica,sans-serif; font-size:14px; line-height:1.6; color:#333333; -webkit-text-size-adjust:100%; -ms-text-size-adjust:100%; text-size-adjust:100%; mso-line-height-rule:exactly; display:block;\">\n\n  <p style=\"margin:0 0 16px; padding:0; font-size:14px; line-height:1.6;\">\n    <strong>Medicure (TSXV: MPH)<\/strong> in our view has a\n    <span style=\"color:#27ae60;\"><strong>100% chance<\/strong><\/span>\n    of getting FDA approval for <strong>MC-1<\/strong>, which will result in them receiving their\n    <strong>Priority Review Voucher<\/strong> that they will sell for\n    <span style=\"color:#27ae60;\"><strong>US$200 million<\/strong><\/span>.\n    <strong>Marley Drug<\/strong> alone is worth\n    <span style=\"color:#27ae60;\"><strong>much more<\/strong><\/span>\n    than MPH&#8217;s current market cap. If you look at how thousands of people are saying on X that they would love to\n    <span style=\"color:#27ae60;\"><strong>invest<\/strong><\/span>\n    in <strong>Cost Plus Drugs<\/strong> if it was a\n    <span style=\"color:#27ae60;\"><strong>publicly traded<\/strong><\/span>\n    company, <strong>Marley Drug<\/strong> is the only\n    <span style=\"color:#27ae60;\"><strong>publicly traded<\/strong><\/span>\n    equivalent. <span style=\"color:#e74c3c;\"><strong>Outside<\/strong><\/span>\n    of the <span style=\"color:#2980b9;\"><strong>natural resource<\/strong><\/span>\n    sector there are <span style=\"color:#e74c3c;\"><strong>no<\/strong><\/span>\n    stocks that will <span style=\"color:#27ae60;\"><strong>outperform<\/strong><\/span>\n    <strong>Medicure in 2027<\/strong>. Its\n    <span style=\"color:#27ae60;\"><strong>big breakout<\/strong><\/span>\n    is coming shortly. This is just like <strong>Broadvision in 2012<\/strong> and\n    <strong>Voyager in 2020<\/strong>.\n  <\/p>\n\n  <p style=\"margin:0 0 16px; padding:0; text-align:center;\">\n    <img decoding=\"async\" src=\"https:\/\/www.inflation.us\/news\/wp-content\/uploads\/2026\/11\/medicure430chart.jpg\"\n         alt=\"Medicure MPH stock price chart\"\n         width=\"600\"\n         height=\"240\"\n         style=\"display:block; width:100%; max-width:600px; height:auto; margin:0 auto; border:0;\" \/>\n  <\/p>\n\n  <p style=\"margin:0 0 16px; padding:0; font-family:Arial,Helvetica,sans-serif; font-size:8px; line-height:1.5; color:#555555;\">\n    <em>Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA&#8217;s President has purchased 87,000 shares of MPH and intends to buy more shares. This message is meant for informational and educational purposes only.<\/em>\n  <\/p>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Medicure (TSXV: MPH) in our view has a 100% chance of getting FDA approval for MC-1, which will result in them receiving their Priority Review Voucher that they will sell for US$200 million. Marley Drug alone is worth much more than MPH&#8217;s current market cap. If you look at how thousands of people are saying [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11142,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[365,414,8],"class_list":["post-11140","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-biotech","tag-mph","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/comments?post=11140"}],"version-history":[{"count":1,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11140\/revisions"}],"predecessor-version":[{"id":11143,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/11140\/revisions\/11143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media\/11142"}],"wp:attachment":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media?parent=11140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/categories?post=11140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/tags?post=11140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}